Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Reasons for Not Prescribing Guideline-recommended Medications to Adults With Heart Failure

Bibliographic Data

ID9099230
AuthorsMichael A Steinman (0000-0002-9564-9480, Health Services Research & Development, corresponding author), Liezel Dimaano (University of California, San Francisco), Carolyn A Peterson (San Francisco VA Medical Center, corresponding author), Paul A Heidenreich (0000-0001-7730-8490, Stanford University), Sara J Knight (0000-0001-9452-9375, University of California, San Francisco), Kathy Z Fung, Kathy Fung (Health Services Research & Development, corresponding author), Peter J Kaboli (0000-0003-0993-0952, Health Services Research & Development, corresponding author)
Year2013
Volume51
Issue10
Pages901-907
Publication date2013-10-01
Open AccessNo
TypeARTICLE
VenueMedical Care (JOURNAL)
Journal identifiersISSN: 0025-7079 • E-ISSN: 1537-1948
PublisherOvid Technologies (Wolters Kluwer Health) (PUBLISHER)
DOI10.1097/mlr.0b013e3182a3e525
PMID23969589
PMCIDPMC3806480
OpenAlexW2044136105
LanguageEN
References cited7

BACKGROUND: Little is known about how often contextual factors such as patient preferences and competing priorities impact prescribing of guideline-recommended medications, or about the extent to which these factors are documented in medical records and available to performance measurement systems. METHODS: Mixed-methods study of 295 veterans aged 50 years and older in 4 VA health care systems who had systolic heart failure and were not prescribed a β-blocker and/or an angiotensin converting enzyme inhibitor or angiotensin-receptor blocker. Reasons for nontreatment were identified from clinic notes and from interviews with 62 primary care clinicians caring for these patients. These reasons were classified using a published taxonomy. RESULTS: Among 295 patients not receiving guideline-recommended drugs for heart failure, chart review identified biomedical reasons for nonprescribing in 42%-58% of patients and contextual reasons in 11%-17%. Clinician interviews identified twice as many reasons for nonprescribing as chart review (mean 1.6 vs. 0.8 reasons per patient, P<0.001). In these interviews, biomedical reasons for nonprescribing were cited in 50%-70% of patients, and contextual reasons in 64%-70%. The most common contextual reasons were comanagement with other clinicians (32%-35% of patients), patient preferences and nonadherence (15%-24%), and clinician belief that the medication is not indicated in the patient (12%-20%). CONCLUSIONS: Contextual reasons for not prescribing angiotensin converting enzyme inhibitor / angiotensin-receptor blockers and β-blockers are present in two thirds of patients with heart failure who did not receive these medications, yet are poorly documented in medical records. The structure of medical records should be improved to facilitate documentation of contextual reasons for not providing guideline-recommended care

Angiotensin Receptor Blockers · Angiotensin-converting enzyme · Blood pressure · Context (archaeology) · Family medicine · Guideline · Heart failure · Intensive care medicine · Medical record · MEDLINE · Chronic Disease Management Strategies · Heart Failure Treatment and Management · Internal Medicine · Medication Adherence and Compliance · Medicine

  • Building a Better Quality Measure

    Eve A Kerr, Dylan M Smith et al.•Medical Care•2003

Highly citedNo

Tools

Open DOISci-HubOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae